Despite ample evidence that medications improve outcomes in heart failure (HF) patients, few Canadians are receiving optimal pharmacotherapy. Recent evidence shows that pharmacist-led medication optimization was linked to improved use of recommended medications for HF. University of British Columbia Assistant Professor and Clinical Pharmacy Specialist Ricky Turgeon and his team will lead an 18-month pilot to determine the feasibility and design of a definitive, large-scale randomized control trial using pharmacist-led, remotely administered intervention to optimize heart failure with reduced rejection fraction (HFrEF) medications—with the ultimate aim that pharmacists become part of a multidisciplinary team for HR patients.
As a registered charity, the Canadian Foundation for Pharmacy (CFP) is uniquely positioned to fund practical research and innovative practice models at the grassroots level, as well as recognize the leaders of today and tomorrow. Our vision is to be a catalyst for change in the profession of pharmacy by seeking out, nurturing and inspiring innovation. Your donations are a way to give back to a profession that has much to look forward to. Thank you for your support.